9 Results for "

BCATm

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "BCATm" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-141669
CAS No.: 1800024-45-6
Purity:  99.07%
Research Areas:  

Metabolic Disease

BCAT-IN-2 is a potent, selective and orally active inhibitor of mitochondrial branched-chain aminotransferase (BCATm), with a pIC50 of 7.3. BCAT-IN-2 shows selectivity for BCATm over BCATc (pIC50=6.6). BCAT-IN-2 can be used for the research of obesity and dislipidema .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W017387
CAS No.: 4502-00-5
Synonyms: Sodium 4-methyl-2-oxopentanoate; 2-Ketoisocaproic acid sodium salt
Sodium α-ketoisocaproate (Sodium 4-methyl-2-oxopentanoate) is an insulin secretagogue. Sodium α-ketoisocaproate undergoes transamination catalyzed by BCAT and BCATm to produce α-ketoglutarate and leucine; it also binds to the SUR1 site to inhibit KATP channel activity, but does not directly affect the Kir6.2 subunit. Sodium α-ketoisocaproate regulates Ca 2+ influx. Sodium α-ketoisocaproate exerts insulinotropic activity in pancreatic islets and intact mouse pancreata with sufficient BCATm expression. Sodium α-ketoisocaproate can be used in research related to type 2 diabetes .
loading...
    loading...
Cat. No.: HY-141668
CAS No.: 1875078-61-7
Purity:  96.40%
Research Areas:  

Metabolic Disease

BCAT-IN-1 is a potent, selective and orally active inhibitor of BCATm, with a pIC50 of 7.3. BCAT-IN-1 shows 100-fold selectivity for BCATm over BCATc (pIC50=5.4). BCAT-IN-1 can be used for the research of metabolic diseases .
loading...
    loading...
Cat. No.: HY-W017387S
CAS No.: 93523-67-2
Synonyms: Sodium 4-methyl-2-oxopentanoate-d3; 2-Ketoisocaproic acid-d3 sodium salt
Sodium α-ketoisocaproate-d3 (Sodium 4-methyl-2-oxopentanoate-d3; 2-Ketoisocaproic acid-d3 (sodium salt)) is the deuterated-labeled Sodium α-ketoisocaproate (HY-W017387). Sodium α-ketoisocaproate (Sodium 4-methyl-2-oxopentanoate) is an insulin secretagogue. Sodium α-ketoisocaproate undergoes transamination catalyzed by BCAT and BCATm to produce α-ketoglutarate and leucine; it also binds to the SUR1 site to inhibit KATP channel activity, but does not directly affect the Kir6.2 subunit. Sodium α-ketoisocaproate regulates Ca 2+ influx. Sodium α-ketoisocaproate exerts insulinotropic activity in pancreatic islets and intact mouse pancreata with sufficient BCATm expression. Sodium α-ketoisocaproate can be used in research related to type 2 diabetes .
loading...
    loading...
Cat. No.: HY-RS01403
Research Areas:  

Others

BCAT2 Human Pre-designed siRNA Set A contains three designed siRNAs for BCAT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P701339
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: BCAT2; Branched-chain-amino-acid aminotransferase; mitochondrial; BCAT(m); Placental protein 18; PP18
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P701340
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: BCAT2; Branched-chain-amino-acid aminotransferase; mitochondrial; BCAT(m); Placental protein 18; PP18
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-RS17299
Research Areas:  

Others

Bcat2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bcat2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS23754
Research Areas:  

Others

Bcat2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Bcat2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...